57 related articles for article (PubMed ID: 368770)
1. Androgen trial in renal anaemia.
Naik RB; Gibbons AR; Gyde OH; Harris BR; Robinson BH
Proc Eur Dial Transplant Assoc; 1978; 15():136-43. PubMed ID: 368770
[TBL] [Abstract][Full Text] [Related]
2. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
3. Androgen therapy for anaemia of chronic renal failure. Indications in the erythropoietin era.
Teruel JL; Aguilera A; Marcen R; Navarro Antolin J; Garcia Otero G; Ortuño J
Scand J Urol Nephrol; 1996 Oct; 30(5):403-8. PubMed ID: 8936631
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
Berns JS; Rudnick MR; Cohen RM
Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
6. [Long-term treatment of renal anaemia with mesterolone (author's transl)].
Kraft D
Dtsch Med Wochenschr; 1980 Jun; 105(23):830-2. PubMed ID: 6447589
[TBL] [Abstract][Full Text] [Related]
7. Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis.
Sheashaa H; Abdel-Razek W; El-Husseini A; Selim A; Hassan N; Abbas T; El-Askalani H; Sobh M
Nephron Clin Pract; 2005; 99(4):c102-6. PubMed ID: 15703460
[TBL] [Abstract][Full Text] [Related]
8. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
Raich PC; Korst DR
Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
[TBL] [Abstract][Full Text] [Related]
9. Epoetin delta in the management of renal anaemia: results of a 6-month study.
Martin KJ;
Nephrol Dial Transplant; 2007 Oct; 22(10):3052-4. PubMed ID: 17660186
[TBL] [Abstract][Full Text] [Related]
10. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
Williams JS; Stein JH; Ferris TF
Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
[No Abstract] [Full Text] [Related]
11. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
[No Abstract] [Full Text] [Related]
12. Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients.
Kwan JT; Pratt RD;
Curr Med Res Opin; 2007 Feb; 23(2):307-11. PubMed ID: 17288685
[TBL] [Abstract][Full Text] [Related]
13. [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis].
Docci D; Feliciangeli G; Mosconi G; Vangelista A; Stefoni S
G Clin Med; 1981 Aug; 62(8):567-75. PubMed ID: 7308639
[No Abstract] [Full Text] [Related]
14. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
[No Abstract] [Full Text] [Related]
15. Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?
Gabutti L; Lötscher N; Bianda J; Marone C; Mombelli G; Burnier M
BMC Nephrol; 2006 Sep; 7():13. PubMed ID: 16981983
[TBL] [Abstract][Full Text] [Related]
16. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
[TBL] [Abstract][Full Text] [Related]
18. Androgen versus erythropoietin for the treatment of anaemia of pre-dialysis chronic kidney disease.
Paul AK; Latif ZA; Iqbal S; Amin F; Shefin SM; Ashrafuzzaman SM
Mymensingh Med J; 2012 Jan; 21(1):125-8. PubMed ID: 22314467
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis ameliorates anaemia in haemodialysis patients.
Lin YL; Lin CW; Lee CH; Lai IC; Chen HH; Chen TW
Nephrology (Carlton); 2008 Jun; 13(4):289-93. PubMed ID: 18331433
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
